Presently, most strategies block mitotic exit at the metaphase-to-anaphase transition via SAC9; unfortunately, reduced SAC activity in cancer cells is commonly found10, new approaches against MTA-resistant cancers are needed. The gene discussed is ADCY10; the disease is cancer.